• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Distribution

Eitan Group inks Canadian distribution deal for Sapphire infusion pumps

September 16, 2019 By Danielle Kirsh

eitan-group-logo

Eitan Group today announced it signed a distribution agreement with Canadian Hospital Specialities to distribute its Sapphire infusion pumps in Canada. Through the agreement, Canadian Hospital Specialties will supply and support Israel-based Eitan Group’s Sapphire infusion pumps to hospitals and alternate site customers in Canada. “CHS works to introduce the most advanced medical technology to […]

Filed Under: Distribution, Drug-Device Combinations, Patient Monitoring Tagged With: Eitan Group

Valeritas inks Israeli distro deal with Tritech Biomed

March 28, 2019 By Fink Densford

Valeritas V-Go device - updated

Valeritas (NSDQ:VLRX) said today that it inked an exclusive distribution deal with Tritech Biomed to commercialize its V-Go wearable insulin delivery device, designed for patients with Type 2 diabetes, in Israel. Through the deal, the Bridgewater, N.J.-based company said that Tritech Biomed will have rights to promote, market and sell the V-Go system to diabetes clinics […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured Tagged With: Valeritas Inc.

Reva brings bioresorbable scaffolds to new markets

January 9, 2019 By Sarah Faulkner

Reva Medical updated logo

Reva Medical (ASX:RVA) said this week that it inked four new distribution agreements, bringing its commercial operations to seven European countries. The San Diego, Calif.-based company said the deals serve to expand the reach of its drug-eluting bioresorbable scaffold, Fantom Encore. Reva said it landed deals with the following companies: A care a.s. in the Czech […]

Filed Under: Business/Financial News, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: Reva Medical

ivWatch inks distro deal for IV monitoring device

November 15, 2018 By Sarah Faulkner

ivWatch logo updated

ivWatch said this week that it landed an international partner to manage the distribution of its continuous intravenous monitoring device. The Hampton, Va.-based company inked a deal with supplier New Medical to distribute its ivWatch Model 400 system in Australia and New Zealand. ivWatch’s sensor, which is roughly the size of a pencil eraser, uses light to […]

Filed Under: Distribution, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals Tagged With: ivwatch

Valeritas inks Middle East distro deal for V-Go insulin delivery device

November 13, 2018 By Sarah Faulkner

Valeritas V-Go device - updated

Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Julphar for the commercialization of its V-Go wearable insulin delivery device in the member states of the Gulf Cooperation Council. Valeritas has deals in place to bring its V-Go device to 14 countries and territories, including Australia, Slovenia and Puerto Rico. The company is […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: julphar, Valeritas Inc.

Otsuka inks collab deal to bring Abilify Mycite drug-device combo to US

August 30, 2018 By Fink Densford

Otsuka Pharmaceuticals

Otsuka Pharmaceutical (TYO:4578) said today it inked a collaborative deal with health management group Magellan Health to distribute its drug-device combo Abilify Mycite in the US. The Tokyo-based pharmaceutical company touted the Abilify Mycite system as the first FDA-approved drug-device combo designed to track drug ingestion, and said that the tracking data will be integrated into […]

Filed Under: Business/Financial News, Distribution, Drug-Device Combinations, Featured, Neurological Tagged With: Otsuka Pharmaceutical

BD inks UAE insulin pen distro deal with Julphar

August 28, 2018 By Fink Densford

Becton Dickinson, Julphar

Pharmaceutical manufacturer Julphar said yesterday it inked a deal with BD (NYSE: BDX) to supply disposable insulin pens to the United Arab Emirates. Through the deal, individuals will be able to purchase BD’s Vystra disposable pens featuring Julphar’s human insulin formulations, including its Jusline R, Jusline N and Jusline 30/70. The same system is slated to be […]

Filed Under: Business/Financial News, Diabetes, Distribution, Drug-Device Combinations, Featured Tagged With: Becton Dickinson, julphar

Valeritas inks distro deal for V-Go device in Austria, Germany

May 21, 2018 By Sarah Faulkner

Valeritas

Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing. Med Trust will take over the sales, marketing and distribution activities […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Valeritas Inc.

Report: Amazon abandons drug distribution and supply plans

April 18, 2018 By Fink Densford

Amazon

Amazon‘s (NSDQ:AMZN) Business division has dropped plans to sell and distribute pharmaceutical products to hospitals, according to a new report from CNBC. The shift comes due to the online mega-retailer being unable to convince large hospital groups to change their purchasing process and break existing deals and relationships with distributors, according to the report. The […]

Filed Under: Business/Financial News, Distribution, Featured, Pharmaceuticals Tagged With: amazon

Valeritas inks distro deal in Australia, New Zealand for V-Go insulin delivery device

April 17, 2018 By Sarah Faulkner

Valeritas V-Go device

Valeritas (NSDQ:VLRX) said today that it inked an exclusive distribution deal with AMSL Diabetes and NZMS Diabetes for the commercialization of its V-Go wearable insulin delivery device in Australia and New Zealand. According to the terms of the agreement, AMSL Diabetes and NZMS Diabetes retain the right to promote, market and sell the V-Go device to clinics and […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Valeritas Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS